The Molecular and Translational Oncology Research (MTOR) Training Program at Weill Cornell Medicine offers 1-2 years training grants to postdoctoral fellows, who have a solid background in basic science and are interested in pursuing a career in translational cancer research.
Directed by Dr. Paraskevi (Evi) Giannakakou and Dr. John Blenis, the MTOR program aims to provide training in the transdisciplinary approaches and communication skills needed to successfully lower the barriers between bench and bedside research, so that they graduate with the skills to contribute to the future of translational cancer research in the US.
Weill Cornell Medicine and the Meyer Cancer Center feature a strong translational patient-focused research program that allows patients enrolled in clinical trials to benefit earlier from laboratory discoveries.
Our outstanding translational environment has been reinforced by the establishment of the Englander Institute for Precision Medicine (IPM) where the strong multidisciplinary team science between physicians and scientists translates lab discoveries to clinical gains.
The rich Tri-Institutional scientific and educational environment, made up of Memorial Sloan Kettering Cancer Center, the Rockefeller University, and Weill Cornell Medicine, provides trainees with unique opportunities to be exposed to groundbreaking scientific discoveries and witness their clinical implementation.
The MTOR training program of WCM is uniquely positioned to train the future leaders in translational cancer research.